A number of drugs have been shown to slow the progression of MS in some people. These are called the disease-modifying drugs. They include:
- alemtuzumab (Lemtrada)
- daclizumab (Zinbryta)
- dimethyl fumarate (Tecfidera)
- fingolimod (Gilenya)
- glatiramer acetate (Copaxone)
- interferon beta-1a (Avonex, Rebif)
- interferon beta-1b (Betaseron)
- mitoxantrone (Novantrone)
- natalizumab (Tysabr)
- ocrelizumab (Ocrevus)
- peginterferon beta-1a (Plegridy)
- teriflumonide (Aubagio)